Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
887 ensayos encontrados
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Parallel-group, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Oral Tropifexor (LJN452) & Licogliflozin (LIK066) Combination Therapy and Each Monotherapy, Compared With Placebo for Treatment of Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis.(ELIVATE)
INTERVENTIONAL
Inicio: 30 de dic de 2019
ID: NCT04065841
Completado
ClinicalTrials.gov
A Post-Marketing, Observational, Comparative Safety Study of the Novartis Pandemic Influenza A (H1N1) Vaccine(s) in Pregnant Women Versus Non-Vaccinated Pregnant Women
OBSERVATIONAL
Inicio: 1 de ene de 2010
ID: NCT01037829
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, 24-Week Study of the Clinical and Antiviral Effect of S-217622 Compared With Placebo in Non-Hospitalized Participants With COVID-19
INTERVENTIONAL
Inicio: 3 de ago de 2022
ID: NCT05305547
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Study of 2 Dose Regimens of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Treatment-Naive Subjects With Genotype 1 Chronic Hepatitis C
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00627926
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Multicenter, Placebo-controlled, Double-blind Clinical Study of the Safety and Efficacy of Carrimycin for Treatment of Severe COVID-19 in Hospitalized Patients
INTERVENTIONAL
Inicio: 30 de mar de 2021
ID: NCT04672564
Terminado
Fase 2
ClinicalTrials.gov
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
INTERVENTIONAL
Inicio: 18 de nov de 2020
ID: NCT04493216
Completado
Fase 2
ClinicalTrials.gov
Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BMS-791325 in Subjects Chronically Infected With Hepatitis C Virus Genotype 1
INTERVENTIONAL
Inicio: 1 de may de 2008
ID: NCT00664625
Completado
ClinicalTrials.gov
Personal Protective Equipmente Needs, Perceptions and Acute Stress Among Healthcare Workers Caring for COVID-19 Patients in South America
OBSERVATIONAL
Inicio: 1 de abr de 2020
ID: NCT04486404
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline Versus Ceftriaxone in Pediatric Subjects With Community-acquired Bacterial Pneumonia Requiring Hospitalization
INTERVENTIONAL
Inicio: 1 de sept de 2012
ID: NCT01530763
Completado
ClinicalTrials.gov
An International Prospective Observational Study to Assess the Characteristics and Outcomes of Post-transplant Patients Treatment for C. Difficile Infections
OBSERVATIONAL
Inicio: 22 de ago de 2016
ID: NCT02747017
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Evaluation of Daclatasvir in Combination With Peginterferon Lambda-1a and Ribavirin (RBV) or Telaprevir in Combination With Peginterferon Alfa-2a and RBV in Patients With Chronic Hepatitis C Genotype 1b Who Are Treatment naïve or Prior Relapsers to Alfa/RBV Therapy (the STRUCTURE Study)
INTERVENTIONAL
Inicio: 1 de ene de 2013
ID: NCT01718158
Completado
Fase 2
ClinicalTrials.gov
An Open-Label Re-Treatment Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01428063
Completado
Fase 3
ClinicalTrials.gov
ING117175: a Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir or Efavirenz Each Administered With Two NRTIs in HIV-1-infected Antiretroviral Therapy-naïve Adults Starting Treatment for Rifampicin-sensitive Tuberculosis
INTERVENTIONAL
Inicio: 23 de ene de 2015
ID: NCT02178592
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Open-Label, Single Arm, Rollover Trial of TMC435 in Combination With Peginterferon Alpha-2A and Ribavirin for HCV Genotype-1 Infected Subjects Who Participated in the Placebo Group of a Phase II/III TMC435 Study, or Who Received DAA Treatment in a Tibotec-Sponsored Phase I Study.
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT01323244
Desconocido
ClinicalTrials.gov
NATIONAL VACCINATION REGISTRY FOR SARS-CoV-2 IN PATIENTS WITH RHEUMATIC DISEASES OF THE ARGENTINE SOCIETY OF RHEUMATOLOGY
OBSERVATIONAL
Inicio: 1 de jul de 2021
ID: NCT04845997
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease
INTERVENTIONAL
Inicio: 11 de dic de 2020
ID: NCT04652518
Completado
ClinicalTrials.gov
Evolution of Quality of Life, Functional Capacity, Nutritional Status and Return to Work Activity in Patients Admitted for Severe Pneumonia Due to COVID 19 Requiring Invasive Mechanical Ventilation
OBSERVATIONAL
Inicio: 1 de jun de 2020
ID: NCT06727474
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
INTERVENTIONAL
Inicio: 28 de may de 2020
ID: NCT04376684
Completado
Fase 3
ClinicalTrials.gov
Randomized, Open-label, Comparative Safety and Efficacy Study of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) Versus Genotypically-defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-experienced Patients (RESIST 2: Randomized Evaluation of Strategic Intervention in Multi-Drug Resistant Patients With Tipranavir)
INTERVENTIONAL
Inicio: 1 de feb de 2003
ID: NCT00144170
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir Once-Daily in HIV-1 Infected Treatment-Naïve Participants
INTERVENTIONAL
Inicio: 28 de feb de 2020
ID: NCT04233879
Anterior
1
...
24
25
26
...
45
Siguiente
Filtros